Resmed Inc
XBER:RME
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Resmed Inc
XBER:RME
|
US |
|
Singapore Airlines Ltd
SGX:C6L
|
SG |
|
K
|
KGHM Polska Miedz SA
F:KGHA
|
PL |
|
Pembina Pipeline Corp
TSX:PPL
|
CA |
|
Guotai Junan Securities Co Ltd
OTC:GUOSF
|
CN |
|
Stellantis NV
F:8TI
|
NL |
|
N
|
Netflix Inc
F:NFC
|
US |
|
C
|
Christian Dior SE
LSE:0NPL
|
FR |
Wall St Price Targets
RME Price Targets Summary
Resmed Inc
According to Wall Street analysts, the average 1-year price target for RME is 279.5 EUR with a low forecast of 46.59 EUR and a high forecast of 359.34 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RME's stock price target?
Price Target
279.5
EUR
According to Wall Street analysts, the average 1-year price target for RME is 279.5 EUR with a low forecast of 46.59 EUR and a high forecast of 359.34 EUR.
What is the Revenue forecast for Resmed Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 5 years is 9%.
What is the Operating Income forecast for Resmed Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 5 years is 11%.
What is the Net Income forecast for Resmed Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 5 years is 11%.
